![Nadia Dac](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nadia Dac
Corporate Officer/Principal chez OMEROS CORPORATION
Profil
Nadia Dac currently works at Omeros Corp., as Chief Commercial Officer from 2021.
Ms. Dac also formerly worked at Auxilium Pharmaceuticals LLC, as Vice President-Marketing from 2013 to 2014, AbbVie, Inc., as VP-Global Specialty Commercial Development from 2014 to 2019, Novartis AG, as VP-Neuroscience Professional Relations from 2009 to 2013, and Lundbeck Seattle BioPharmaceuticals, Inc., as Chief Commercial Officer from 2019 to 2020.
Ms. Dac received her undergraduate degree from Rutgers State University of New Jersey.
Postes actifs de Nadia Dac
Sociétés | Poste | Début |
---|---|---|
OMEROS CORPORATION | Corporate Officer/Principal | 26/01/2021 |
Anciens postes connus de Nadia Dac
Sociétés | Poste | Fin |
---|---|---|
ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2020 |
ABBVIE INC. | Corporate Officer/Principal | 01/03/2019 |
AUXILIUM PHARMACEUTICALS, INC. | Sales & Marketing | 01/09/2014 |
NOVARTIS AG | Corporate Officer/Principal | 01/01/2013 |
Formation de Nadia Dac
Rutgers State University of New Jersey | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
OMEROS CORPORATION | Health Technology |
ABBVIE INC. | Health Technology |
NOVARTIS AG | Health Technology |
Entreprise privées | 2 |
---|---|
Lundbeck Seattle BioPharmaceuticals, Inc.
![]() Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Auxilium Pharmaceuticals LLC
![]() Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |